We found that serum levels of three proinflamatory adipokines (chemerin, lipocalin-2 and resistin) were increased, while serum levels of one anti-inflammatory adipokine, adiponectin, were decreased in psoriasis patients. Here, LCN2 is linked to psoriasis.